San Diego, CA, United States of America

Mark Stidham

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
4 patents (USPTO):

Title: Mark Stidham: Innovator in Antibiotic Research

Introduction

Mark Stidham, an accomplished inventor based in San Diego, California, has made significant contributions to the field of pharmaceutical innovation. With a total of four patents to his name, his work focuses primarily on developing novel treatments targeting bacterial infections and related diseases.

Latest Patents

Among Mark Stidham's noteworthy patents are advancements in the area of dihydrofolate reductase (DHFR) inhibitors. His latest patent outlines compounds aimed at treating cell proliferative diseases, autoimmune diseases, inflammatory diseases, and various infections by inhibiting DHFR activity. Notably, this patent provides pharmaceutical compositions and detailed methodologies for utilizing these compounds effectively.

Another significant invention by Stidham involves the identification and application of antibiotic synergy. This innovative patent proposes a pharmaceutical composition designed for treating bacterial infections in both humans and animals. The composition includes an antibacterial combination of a β-lactam antibiotic and an inhibitor of bacterial peptidoglycan biosynthesis enzymes. This work also encompasses a novel method for discovering synergistic antibiotic combinations that enhance efficacy against bacterial pathogens.

Career Highlights

Stidham's career is marked by his dedication to advancing antibiotic research. His tenure at Trius Therapeutics, Inc. has allowed him to collaborate on groundbreaking projects aimed at tackling pressing health challenges caused by antibiotic resistance. His proactive approach has positioned him as a notable figure in pharmaceutical research.

Collaborations

Throughout his career, Mark Stidham has collaborated with talented professionals, including his colleagues Mark Hilgers and Vickie L. Brown-Driver. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their research efforts.

Conclusion

Mark Stidham's contributions to antibiotic research exemplify the spirit of innovation in the pharmaceutical industry. With multiple patents focusing on effective treatments for bacterial infections and related diseases, he continues to inspire advancements in science and medicine. His work at Trius Therapeutics, Inc., along with his collaborations, showcases the importance of teamwork and ingenuity in the pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…